Literature DB >> 10619272

Coronary ectasia in familial hypercholesterolemia: histopathologic study regarding matrix metalloproteinases.

K Kajinami1, S Kasashima, Y Oda, J Koizumi, S Katsuda, H Mabuchi.   

Abstract

A 39-year-old male heterozygous familial hypercholesterolemia patient with marked ectasia over the entire coronary artery tree had been treated with several kinds of lipid-lowering single or combined drug therapies using clofibrate, compactin, cholestyramine, probucol, and pravastatin, and LDL-apheresis. During the 19-year follow-up, he suffered myocardial infarction three times and some of the ectatic coronary segments became enlarged, others narrowed, and one of them occluded in spite of the treatment. At the age of 58, he died after a fourth cardiac attack and subsequent cardiogenic shock. The autopsy indicated that his three coronary arteries showed diffuse ectatic changes and the largest lumen diameter of the left anterior descending artery was 25 mm, of the circumflex artery 12 mm, and of the right coronary artery 13 mm. The ectatic artery wall was not thick and the major part of the lumen was occupied by organized thrombi. Microscopic examinations showed that the larger the diameter of the lumen, the more severe the structural damage of the intima and tunica media and the larger the number of infiltrated cells, including lymphocytes, macrophages, and plasma cells. Immunoreactivity against matrix metalloproteinase (MMP)-1, and MMP-2 was observed in smooth muscle cells, macrophages, lymphocytes, and endothelial cells of the vasa vasorum or neovasculature. MMP-9 immunoreactivity was also localized in intimal foamy macrophages and round cells (macrophages and lymphocytes) of the media and adventitia. MMP-1 increased with the lumen diameter of the ectatic arteries. The ratio of immunoreactivity against both MMP-2 and MMP-9 to that against tissue inhibitor of metalloproteinase (TIMP)-2 also increased with the lumen diameter, but it no longer increased when the diameter was over 10 mm. These observations suggest that the MMP-TIMP system appears to play a significant role in the development of coronary ectasia

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10619272

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  8 in total

1.  The association between soluble lectin-like oxidized low-density lipoprotein receptor-1 levels and patients with isolated coronary artery ectasia.

Authors:  Mehmet Balin; Ahmet Celik; M Ali Kobat
Journal:  J Thromb Thrombolysis       Date:  2012-04       Impact factor: 2.300

2.  Further increase in the expression of activation markers on monocyte-derived dendritic cells in coronary artery disease patients with ectasia compared to patients with coronary artery disease alone.

Authors:  Nesligul Yildirim; Ishak Ozel Tekin; Mehmet Arasli; Mustafa Aydin
Journal:  Mediators Inflamm       Date:  2010-06-14       Impact factor: 4.711

3.  Usefulness of Neutrophil to Lymphocyte Ratio in Prediction of Coronary Artery Lesions in Patients with Kawasaki Disease.

Authors:  Fikri Demir; Cem Karadeniz; Rahmi Özdemir; Yılmaz Yozgat; Kübra Çelegen; Utku Karaaslan; Mustafa Demirol; Timur Meşe; Nurettin Ünal
Journal:  Balkan Med J       Date:  2015-10-01       Impact factor: 2.021

4.  Association of C-Reactive Protein to Albumin Ratio in Patients with Isolated Coronary Artery Ectasia.

Authors:  Alper Sercelik; Okan Tanrıverdi; Lutfu Askin; Serdar Turkmen
Journal:  Arq Bras Cardiol       Date:  2021-01       Impact factor: 2.000

5.  Among Ectasia Patients with Coexisting Coronary Artery Disease, TIMI Frame Count Correlates with Ectasia Size and Markis Type IV Is the Commonest.

Authors:  Hasahya Tony; Kai Meng; Bangwei Wu; Qiutang Zeng
Journal:  Cardiol Res Pract       Date:  2015-02-03       Impact factor: 1.866

6.  Association of systemic immune-inflammation index (SII) with presence of isolated coronary artery ectasia.

Authors:  Aydın Rodi Tosu; Halil İbrahim Biter
Journal:  Arch Med Sci Atheroscler Dis       Date:  2021-09-20

7.  The level of hs-CRP in coronary artery ectasia and its response to statin and angiotensin-converting enzyme inhibitor treatment.

Authors:  Yilmaz Ozbay; Mehmet Akbulut; Mehmet Balin; Hidayet Kayancicek; Adil Baydas; Hasan Korkmaz
Journal:  Mediators Inflamm       Date:  2006-12-27       Impact factor: 4.711

8.  Association of serum prolidase activity in patients with isolated coronary artery ectasia.

Authors:  Erdal Aktürk; Lütfü Aşkın; Hüseyin Nacar; M Hakan Taşolar; Serdar Türkmen; Mustafa Çetin; Mehmet Bozkurt
Journal:  Anatol J Cardiol       Date:  2018-01-17       Impact factor: 1.596

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.